197 related articles for article (PubMed ID: 32559027)
21. Estradiol-Induced Potentiation of Dopamine Release in Dorsal Striatum Following Amphetamine Administration Requires Estradiol Receptors and mGlu5.
Song Z; Yang H; Peckham EM; Becker JB
eNeuro; 2019; 6(1):. PubMed ID: 30766916
[TBL] [Abstract][Full Text] [Related]
22. Deletion of Melanin-Concentrating Hormone Receptor-1 gene accentuates D-amphetamine-induced psychomotor activation but neither the subsequent development of sensitization nor the expression of conditioned activity in mice.
Tyhon A; Lakaye B; Grisar T; Tirelli E
Pharmacol Biochem Behav; 2008 Feb; 88(4):446-55. PubMed ID: 17996928
[TBL] [Abstract][Full Text] [Related]
23. Fas and GIT1 signalling in the prefrontal cortex mediate behavioural sensitization to methamphetamine in mice.
Shao X; Liu L; Wei F; Liu Y; Wang F; Yi J; Sun L; Huang Y; Song Z; Yin W; Zhao H; Li Y
Brain Res Bull; 2020 Nov; 164():361-371. PubMed ID: 32777257
[TBL] [Abstract][Full Text] [Related]
24. Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [
Streffer J; Treyer V; Buck A; Ametamey SM; Blagoev M; Maguire RP; Gautier A; Auberson YP; Schmidt ME; Vranesic IT; Gomez-Mancilla B; Gasparini F
Neuroimage; 2021 Apr; 230():117785. PubMed ID: 33545349
[TBL] [Abstract][Full Text] [Related]
25. 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants.
Auclair A; Drouin C; Cotecchia S; Glowinski J; Tassin JP
Eur J Neurosci; 2004 Dec; 20(11):3073-84. PubMed ID: 15579162
[TBL] [Abstract][Full Text] [Related]
26. Cellular distribution of AMPA receptor subunits and mGlu5 following acute and repeated administration of morphine or methamphetamine.
Herrold AA; Persons AL; Napier TC
J Neurochem; 2013 Aug; 126(4):503-17. PubMed ID: 23711322
[TBL] [Abstract][Full Text] [Related]
27. Changes in Proenkephalin mRNA expression in forebrain areas after amphetamine-induced behavioural sensitization.
Morales-Mulia M; Panayi F; Lambás-Señas L; Scarna H; Méndez M
Pharmacol Biochem Behav; 2007; 87(2):232-40. PubMed ID: 17537495
[TBL] [Abstract][Full Text] [Related]
28. State-dependent behavioural sensitization: evidence from a chlordiazepoxide state.
Stephens DN; Elliman TD; Dunworth SJ
Behav Pharmacol; 2000 Apr; 11(2):161-7. PubMed ID: 10877121
[TBL] [Abstract][Full Text] [Related]
29. Amphetamine sensitization alters reward processing in the human striatum and amygdala.
O'Daly OG; Joyce D; Tracy DK; Azim A; Stephan KE; Murray RM; Shergill SS
PLoS One; 2014; 9(4):e93955. PubMed ID: 24717936
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal Characterization of mGluR5 Using
Bertoglio D; Kosten L; Verhaeghe J; Thomae D; Wyffels L; Stroobants S; Wityak J; Dominguez C; Mrzljak L; Staelens S
J Nucl Med; 2018 Nov; 59(11):1722-1727. PubMed ID: 29794227
[TBL] [Abstract][Full Text] [Related]
31. Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine.
Pogarell O; Koch W; Pöpperl G; Tatsch K; Jakob F; Mulert C; Grossheinrich N; Rupprecht R; Möller HJ; Hegerl U; Padberg F
Psychiatry Res; 2007 Dec; 156(3):251-5. PubMed ID: 17993266
[TBL] [Abstract][Full Text] [Related]
32. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
[TBL] [Abstract][Full Text] [Related]
33. Metabotropic glutamate receptor 5 (mGlu
Hellyer SD; Albold S; Sengmany K; Singh J; Leach K; Gregory KJ
J Neurochem; 2019 Nov; 151(3):301-315. PubMed ID: 31376155
[TBL] [Abstract][Full Text] [Related]
34. The impact of 3,4-methylendioxymetamphetamine (MDMA) abstinence on seeking behavior and the expression of the D
Frankowska M; Miszkiel J; Pomierny-Chamiolo L; Pomierny B; Celeste Borelli A; Suder A; Filip M
J Physiol Pharmacol; 2020 Aug; 71(4):. PubMed ID: 33316768
[TBL] [Abstract][Full Text] [Related]
35. VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy.
Nickols HH; Yuh JP; Gregory KJ; Morrison RD; Bates BS; Stauffer SR; Emmitte KA; Bubser M; Peng W; Nedelcovych MT; Thompson A; Lv X; Xiang Z; Daniels JS; Niswender CM; Lindsley CW; Jones CK; Conn PJ
J Pharmacol Exp Ther; 2016 Jan; 356(1):123-36. PubMed ID: 26503377
[TBL] [Abstract][Full Text] [Related]
36. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.
Tessari M; Pilla M; Andreoli M; Hutcheson DM; Heidbreder CA
Eur J Pharmacol; 2004 Sep; 499(1-2):121-33. PubMed ID: 15363959
[TBL] [Abstract][Full Text] [Related]
37. In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5.
DeLorenzo C; DellaGioia N; Bloch M; Sanacora G; Nabulsi N; Abdallah C; Yang J; Wen R; Mann JJ; Krystal JH; Parsey RV; Carson RE; Esterlis I
Biol Psychiatry; 2015 Feb; 77(3):266-275. PubMed ID: 25156701
[TBL] [Abstract][Full Text] [Related]
38. Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5).
Sephton SM; Herde AM; Mu L; Keller C; Rüdisühli S; Auberson Y; Schibli R; Krämer SD; Ametamey SM
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):128-37. PubMed ID: 25139517
[TBL] [Abstract][Full Text] [Related]
39. Quantitative evaluation of 11C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillator.
Wyss MT; Ametamey SM; Treyer V; Bettio A; Blagoev M; Kessler LJ; Burger C; Weber B; Schmidt M; Gasparini F; Buck A
Neuroimage; 2007 Apr; 35(3):1086-92. PubMed ID: 17320417
[TBL] [Abstract][Full Text] [Related]
40. Behavioral sensitization due to social defeat stress in mice: antagonism at mGluR5 and NMDA receptors.
Yap JJ; Covington HE; Gale MC; Datta R; Miczek KA
Psychopharmacology (Berl); 2005 Apr; 179(1):230-9. PubMed ID: 15517195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
